Model Medicines

San Diego, CA · Founded 2019 · Privately Held (backing)

Developer of an artificial intelligence-driven drug discovery platform designed to accelerate the creation of life-changing drugs. Model Medicines is based in San Diego, CA and was founded in 2019. It was valued at $81.3 million at its seed round in Nov 2025, the last priced event on record. It has raised $18.8 million across 4 recorded rounds; the latest was a $3.3 million seed round in Oct 2025.

PMV mark · valuation
$81.3M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$18.8M
Last round
Seed Round
Oct 2025
What is Model Medicines worth?
$81.3MPrivateMarketView mark · Oct 2026

Valued at $81.3M at its seed round, Nov 2025. Nothing has traded since.

Free account
More of Model Medicines with a free account
  • ·Watch Model Medicines: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Model Medicines funding history

4 rounds
DateRoundRaisedPost-money
Oct 2025Seed Round$3.3M▮
Sep 2024Early Stage VC$14.8M▮
Dec 2023Seed Round$950K▮
Aug 2020Seed Round$3.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Model Medicines valuation

Model Medicines was valued at $81.3 million at its seed round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Model Medicines raised?

Model Medicines has raised $18.8 million across 4 recorded rounds since 2020. The largest was a $950,000 seed round in Dec 2023; the most recent was a $3.3 million seed round in Oct 2025.

Model Medicines has filed 4 Form Ds with the SEC since 2021, most recently in Nov 2025 ($3.3 million sold to 10 investors).

How Model Medicines's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Model Medicines, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Model Medicines

What is Model Medicines worth?
Model Medicines is valued at $81.3M as of Oct 2026. Valued at $81.3M at its seed round, Nov 2025. Nothing has traded since.
How much has Model Medicines raised?
Model Medicines has raised $18.8M in total funding across 4 recorded rounds.
When did Model Medicines last raise?
Model Medicines last raised in Oct 2025 (Seed Round), raising $3.3M.